Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
132 hedge funds and large institutions have $42.9M invested in Vaxart in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 30 closing their positions.
830% more call options, than puts
Call options by funds: $781K | Put options by funds: $84K
0% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 39
6.39% less ownership
Funds ownership: 40.15% → 33.76% (-6.4%)
8% less funds holding
Funds holding: 143 → 132 (-11)
30% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 30
61% less capital invested
Capital invested by funds: $111M → $42.9M (-$67.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$2.89M |
| 2 |
Two Sigma Investments
New York
|
+$2.55M |
| 3 |
Millennium Management
New York
|
+$2.27M |
| 4 |
E
Ergoteles
New York
|
+$1.47M |
| 5 |
Renaissance Technologies
New York
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$16.5M |
| 2 |
Rafferty Asset Management
New York
|
-$2.3M |
| 3 |
Citigroup
New York
|
-$1.35M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.2M |
| 5 |
Goldman Sachs
New York
|
-$925K |
VXRT Hedge Fund Activity: Q4 2022 in Review
132 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2022, worth a combined $42.9M — down 61% from $111M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of VXRT and 21 opened new positions — a net loss of 9 holders — while 39 trimmed existing stakes and 39 added.
The largest buyer was Two Sigma Advisers, adding an estimated $2.89M. The largest seller was State Street, cutting an estimated $16.5M.
- 132 institutional investors held Vaxart (VXRT) as of Q4 2022, down from 143 in Q3 2022.
- Funds reported $42.9M of Vaxart stock for Q4 2022, down 61% quarter-over-quarter.
- 21 funds opened new Vaxart positions in Q4 2022 and 30 closed out, a net change of -9 holders.
- The largest Vaxart buyer in Q4 2022 was Two Sigma Advisers, an estimated $2.89M added.
- The largest Vaxart seller in Q4 2022 was State Street, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2022.